Connect with us

General

Cardiex (ASX:CDX) share price rises 6% on new patent // Motley Fool Australia

Published

on

ADVERTISEMENT

The Cardiex Ltd (ASX: CDX) share price was rising today as the company announced it had received a new blood pressure patent. The Cardiex share price closed today’s trading 6.12% higher at 5.2 cents.

What Cardiex does

Cardiex is a global health technology company that focuses on hypertension, cardiovascular disease, and other vascular health disorders.

The company’s ATCOR division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its unique FDA-cleared and patented technology.

Under the ATCOR.X brand, the company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The company’s digital platform, ArtyNet, is a…



Click here to view the original article.

General

3 FAANG stocks to buy right now // Motley Fool Australia

Published

on

ADVERTISEMENT

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Investing in 2020 hasn’t been easy. The uncertainty created by the coronavirus pandemic ushered in a steep bear market decline during the first quarter, which was followed by a ferocious snap-back rally that took the S&P 500 Index (INDEXSP: .INX) to new highs.

Yet, while most investors and equities were suffering from volatility-induced whiplash, the FAANG stocks have been kicking butt and taking names.

These industry leaders have been unstoppable for some time

By FAANG, I’m referring to:


On a year-to-date basis, the benchmark S&P 500 is up 6%, through to 21 October. By comparison, Facebook, Amazon, Apple, Netflix,…



Click here to view the original article.

Continue Reading

General

Leading brokers name 3 ASX shares to buy today 26 October 2020 // Motley Fool Australia

Published

on

ADVERTISEMENT

With so many shares to choose from on the ASX, it can be hard to decide which ones to buy.

The good news is that brokers across the country are doing a lot of the hard work for you.

Three top shares that leading brokers have named as buys this week are listed below. Here’s why they are bullish on them:

National Australia Bank Ltd (ASX: NAB)

According to a note out of UBS, its analysts have retained their buy rating and $20.50 price target on this banking giant’s shares following its provisions update. UBS remains positive despite NAB revealing that its second half result will be reduced by a net increase in provisions and impairments of $642 million. It likes the bank due to its experienced management team and strong balance…



Click here to view the original article.

Continue Reading

General

Why Adore Beauty, Adairs, Marley Spoon, & Resolute shares are dropping lower // Motley Fool Australia

Published

on

ADVERTISEMENT

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) has given back the majority of its morning gains and is trading just slightly higher. At the time of writing the benchmark index is up 1.8 points to 6,168.8 points.

Four shares that have failed to follow the market higher today are listed below. Here’s why they are dropping lower:

Adore Beauty Group Ltd (ASX: ABY)

The Adore Beauty share price is sinking 7% lower to $6.42. This decline means the newly listed online beauty retailer’s shares are now trading below their IPO price of $6.75. Concerns over the reasonably lofty multiples that its shares trade at appear to be behind this decline.

The Adairs share price has tumbled 6.5% to $3.61. This follows the release of the…



Click here to view the original article.

Continue Reading

Trending

You might also like ...

Infratril (ASX:IFT) share price up on acquisition bid // Motley Fool Australia
Zebit Inc (ASX:ZBT) share price crashes 21% lower following IPO // Motley Fool Australia
I think the A2 Milk (ASX:A2M) share price is strong buy // Motley Fool Australia